BIOMAT Database Logo BIOMAT Database Logo

[Reactive arthritis. Diagnosis, differential diagnosis and therapy]. 1999

G R Burmester, and E Feist, and A Krause
Klinik mit Schwerpunkt Rheumatologie u. Klinische Immunologie, Universitätsklinikum Charité, Berlin.

UI MeSH Term Description Entries
D008297 Male Males
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

G R Burmester, and E Feist, and A Krause
[Diagnosis and therapy of reactive arthritis].
November 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
G R Burmester, and E Feist, and A Krause
[Reactive arthritis: pathogenesis, diagnosis and therapy].
March 1992, Zeitschrift fur arztliche Fortbildung,
G R Burmester, and E Feist, and A Krause
[Rheumatic fever and Yersinia reactive arthritis--differential diagnosis].
January 1988, Medicinski pregled,
G R Burmester, and E Feist, and A Krause
[Rheumatic fever, seronegative and "reactive" arthritis. Differential diagnosis].
January 1980, Srpski arhiv za celokupno lekarstvo,
G R Burmester, and E Feist, and A Krause
[Differential diagnosis and therapy of psoriatic arthritis].
February 1976, Zeitschrift fur Hautkrankheiten,
G R Burmester, and E Feist, and A Krause
[Differential diagnosis and therapy of uric arthritis].
January 1968, Beitrage zur Rheumatologie,
G R Burmester, and E Feist, and A Krause
[Rheumatoid arthritis. 2: Differential diagnosis and therapy].
November 1998, Fortschritte der Medizin,
G R Burmester, and E Feist, and A Krause
[Differential diagnosis & therapy of acute arthritis].
May 1959, Deutsches medizinisches Journal,
G R Burmester, and E Feist, and A Krause
[Reactive arthritis. Differential diagnosis in cases of temporomandibular diseases].
January 1988, Den Norske tannlaegeforenings tidende,
G R Burmester, and E Feist, and A Krause
[Reactive forms of arthritis. 2: Epidemiology, diagnosis and therapy].
January 1987, Zeitschrift fur arztliche Fortbildung,
Copied contents to your clipboard!